Skip to content
Saturday, November 14, 2026
Spin Prime Magazine

Zimbabwe Declines ‘Lopsided’ American Healthcare Assistance Agreement Because of Information Concerns

Health aid illustration
The proposed American financial assistance was aimed at initiatives for HIV/Aids treatment and prevention, tuberculosis, and malaria.

Zimbabwe has rejected a substantial US healthcare agreement worth 367 million US dollars (272 million pounds) over five years because of the United States' request for confidential information.

The decision came to light following a internal memorandum dated December was disclosed, revealing that President Emmerson Mnangagwa felt the deal was "unbalanced".

A government spokesperson later stated that the United States was demanding access to biological samples for research and commercial gain while refused to guarantee the benefits from future medical innovations.

"We will now turn to the difficult and regrettable process of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the US had donated more than $1.9bn as health assistance to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has urged more dialogue to find a agreement suitable to all parties so the nation's vital HIV programme can continue.

Wider Background

Zimbabwe's decision follows a similar case in neighbouring Kenya, where a court blocked a similar health funding agreement following concerns were raised about the security of citizens' medical information.

Since resuming office last year, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.

USAID had managed assistance for the American government, but Trump argued its spending was "wasteful" and his government was seeking government-to-government deals to boost transparency and responsibility.

According to reports, Sixteen African countries have to date signed these new health pacts, constituting over $18.3bn of fresh investment.

Specifics of the Declined Deal

The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this collaboration would have delivered extraordinary advantages for Zimbabwean communities, particularly the 1.2 million presently receiving antiretroviral therapy via US-supported programmes," Tremont added.

However, official spokesman Nick Mangwana argued the proposed deal was "unfair".

"The proposal required Zimbabwe to surrender its biological resources and data over an extended period, without any corresponding assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.

"In essence, our nation would provide the basic resources for medical research without any assurance that the final treatments would be accessible to our population should a new disease outbreak emerge."

National Interest and International Frameworks

He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting frameworks already established via the international organization.

Mangwana gave as an example its Pandemic Benefit-Sharing framework created to deal with future pandemics.

"This system is designed to ensure that when a nation provides its information, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to create them."

The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We are open to further discussions with our American counterparts on how future collaboration could be designed in a manner that respects the independence and dignity of both nations."

Health Experts Response

A leading public health body said it acknowledged the official position, but recommended that negotiations need to persist since much of the nation's Aids initiatives were funded by foreign aid.

"In cases where technical issues exist, such as those involving data governance or agreement terms, these can often be addressed via detailed discussion and negotiated safeguards," the group added.

The halted deal highlights the ongoing debate between accepting vital foreign assistance and protecting local interests in an ever more data-driven world.

About the author

Zachary Hancock

A seasoned tech journalist with over a decade of experience covering digital transformation and startup ecosystems across Europe.

Spin Prime Magazine

Type to search articles.